EGFR is thought to play a relevant role in glioma pathogenesis, acting at the level of the initiating stages of tumor development and intervening in the induction of many features of the malignant phenotype of glioma cells, including tumor growth, tumor infiltration, and invasiveness and resistance to chemotherapy. The gene discussed is EGFR; the disease is central nervous system cancer.